Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Micron Biomedical Secures $14M Series A Round

2022-11-28
ATLANTA, GA, Micron Biomedical, a clinical stage life sciences company, announced a $14 million Series A financing.
Micron Biomedical, is a clinical stage life sciences company advancing its Micro Array Patch (MAP) technology for self-administration and simple, less-skilled caregiver administration of drugs and vaccines without needles. The $14 million Series A financing will support the company's development of commercial manufacturing, currently underway and establishes a strong partnership between Micron and LTS Lohmann.

Global Health Investment Corporation and LTS Lohmann led the Series A financing with participation from GRA Venture Fund.

Micron is an Atlanta-based company whose MAP technology was initially developed in Dr. Mark Prausnitz's labs at Georgia Tech. Micron has further developed the technology and emerged as a leader in the field of dissolvable microarray-based, drug and vaccine delivery technology.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors